Our customers' Feedback
Search:
Perform search
Categories list

Generic Symbicort

News
Symbicort
Symbicort photo

Generic Symbicort (Budesonide Formoterol)

Anti-inflammatories, Asthma

PackagePricePer ItemSavingsOrder
100mcg + 6mcg 120 dpi × 1 inhaler$34.95$34.95Add to cart
100mcg + 6mcg 120 dpi × 2 inhaler$59.95$29.98$9.95Add to cart

PackagePricePer ItemSavingsOrder
160mcg + 4.5mcg 60 dpi × 1 inhaler$69.95$69.95Add to cart
160mcg + 4.5mcg 60 dpi × 2 inhaler$129.95$64.97-Add to cart

PackagePricePer ItemSavingsOrder
200mcg + 6mcg 120 dpi × 1 inhaler$39.95$39.95Add to cart
200mcg + 6mcg 120 dpi × 2 inhaler$69.95$34.98$9.95Add to cart

PackagePricePer ItemSavingsOrder
400mcg + 6mcg 120 dpi × 1 inhaler$44.95$44.95Add to cart
400mcg + 6mcg 120 dpi × 2 inhaler$79.95$39.98$9.95Add to cart

Most popular quantity.
Temovate
$ 3.00
Generic Temovate
(Clobetasol 0.05% 15g)
Ventolin
$ 0.50
Generic Ventolin
(Albuterol (salbutamol) 2/4mg)
Ventolin Inhaler
$ 13.74
Generic Ventolin Inhaler
(Albuterol 100mcg 200dpi)
Volmax Cr
$ 0.51
Generic Volmax Cr
(Albuterol (salbutamol) 4/8mg)
Voltaren
$ 0.58
Generic Voltaren
(Diclofenac Sodium 50/100mg)
Xylocaine
$ 5.00
Generic Xylocaine
(Lidocaine 2% 30g)
Social bookmarks:
Articles
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • Prescription plan prices don't always make sense - Allentown Morning Call

    Allentown Morning CallPrescription plan prices don't always make senseAllentown Morning CallFor example, he said, Symbicort is an inhaler with 120 puffs per bottle.

  • After Last Week What Do Analysts Think Of Astrazeneca PLC (NYSE:AZN) - Share Trading News

    After Last Week What Do Analysts Think Of Astrazeneca PLC (NYSE:AZN)Share Trading NewsAstraZeneca offers various products, including Accolate, Rhinocort, Bricanyl Turbuhaler, Rhinocort, Symbicort pMDI, Crestor, Seloken/Toprol-XL, Brilinta/Brilique (ticagrelor), Bydureon, Xigduo XR, Kombiglyze XR and metformin XR, among others.

  • Can AstraZeneca plc (AZN) New Drugs Replace Near-To-Expire Crestor? - Business Finance News

    Business Finance NewsCan AstraZeneca plc (AZN) New Drugs Replace Near-To-Expire Crestor?Business Finance NewsAstraZeneca has a well-established profile in the therapeutic market of asthma and Chronic Obstructive Pulmonary Disease (COPD) with its drugs such as Symbicort, which generated revenue of $3,394 with a negative median of 10.

  • SYMBICORT Real-World Study Results Published in the International Journal of COPD - Business Wire (press release)

    SYMBICORT Real-World Study Results Published in the International Journal of COPDBusiness Wire (press release)This is the first US real-world study to examine the comparative effectiveness of SYMBICORT® 160/4.

  • What Is Symbicort? What You Should Know About This Asthma Drug - NerdWallet (blog)

    What Is Symbicort? What You Should Know About This Asthma DrugNerdWallet (blog)AstraZeneca says that the most common side effects of Symbicort in asthma patients include headache, upper respiratory tract infections, nose and throat irritation, sinus infection, congestion, nausea and vomiting, back pain, stomachache, and thrush .

    Copyright © cheapgenerics24.com